Home / Technology / FDA Reverses Stance on Whoop Blood Pressure Feature
FDA Reverses Stance on Whoop Blood Pressure Feature
24 Jun
Summary
- FDA withdrew its complaint against Whoop's blood pressure tool.
- Whoop can continue offering the blood pressure feature.
- The FDA's decision marks an about-face from its initial request.
The U.S. Food and Drug Administration has withdrawn its complaint against Whoop Inc. concerning the company's blood-pressure tracking feature. This significant reversal follows the FDA's earlier directive for Whoop to disable the tool.
As of Tuesday, Whoop is permitted to continue offering its blood-pressure monitoring functionality. The agency's initial action had prompted concerns about the feature's availability to users. This latest decision signifies a change in the FDA's position on the fitness tracker's innovative health-monitoring capability.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
